tiprankstipranks
Sumitomo Pharma Reports Profit and Revenue Growth
Company Announcements

Sumitomo Pharma Reports Profit and Revenue Growth

Sumitomo Dainippon Pharma Co (JP:4506) has released an update.

Don't Miss Our Christmas Offers:

Sumitomo Dainippon Pharma Co has reported a significant turnaround with a net profit of 15.9 billion JPY in Q1 FY2024 from a net loss of 38.9 billion JPY in Q1 FY2023, attributed to reduced SG&A and R&D expenses. The company also experienced a revenue increase of 19.8% year-over-year and has forecasted further financial developments amidst currency fluctuations. Additionally, operating cash flow has improved, although cash and cash equivalents saw a slight decrease.

For further insights into JP:4506 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskSumitomo Dainippon Pharma Reports Improved Financials
TipRanks Japan Auto-Generated NewsdeskSumitomo Pharma Streamlines Workforce with Retirement Program
TipRanks Japan Auto-Generated NewsdeskSumitomo Pharma Reports Significant Forex Losses
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App